Latest & greatest articles for surgery

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on surgery or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on surgery and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for surgery

3541. Vascular surgery for arteriosclerosis in the legs

Vascular surgery for arteriosclerosis in the legs Vascular surgery for arteriosclerosis in the legs Vascular surgery for arteriosclerosis in the legs Svensson M, Stenberg B, Asztely M, Jernberger A, Jonsson E, Marke L A, Magnusson S Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Svensson M, Stenberg B, Asztely M, Jernberger A, Jonsson E (...) , Marke L A, Magnusson S. Vascular surgery for arteriosclerosis in the legs. Stockholm: Swedish Council on Technology Assessment in Health Care (SBU) 1989: 100 Authors' objectives To evaluate the use of vascular surgery as a treatment for disorders which appear due to arteriosclerosis in the legs. Authors' conclusions Patients with symptoms of arteriosclerosis in the legs should be urged to quit smoking. Patients with intermittent lameness should be offered systematic walking exercises. Except

Health Technology Assessment (HTA) Database.1989

3542. Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery.

Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery. 2563409 1989 03 15 1989 03 15 2015 06 16 0140-6736 1 8632 1989 Feb 04 Lancet (London, England) Lancet Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery. 231-3 Twelve patients admitted for elective resection of carcinoma of colon or rectum were allocated at random to experimental and control groups (six in each (...) , Stuttgart, Federal Republic of Germany. Zander J J Mertes N N Albers S S Puchstein C C Lawin P P Fürst P P eng Clinical Trial Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't England Lancet 2985213R 0140-6736 0 Dipeptides 0RH81L854J Glutamine 8D40GXI4MA alanylglutamic acid N762921K75 Nitrogen AIM IM Lancet. 1989 May 13;1(8646):1085-6 2566039 Clinical Trials as Topic Colonic Neoplasms metabolism surgery Dipeptides administration & dosage metabolism pharmacology Female

Lancet1989

3543. Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery.

Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery. 2648144 1989 04 28 1989 04 28 2013 11 21 0028-4793 320 13 1989 Mar 30 The New England journal of medicine N. Engl. J. Med. Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery. 840-3 We carried out a placebo-controlled, double-blind, randomized study of the hemostatic effect of tranexamic acid mouthwash after oral surgery in 39 patients (...) receiving anticoagulant agents because of the presence of cardiac valvular stenosis, a prosthetic cardiac valve, or a vascular prosthesis. Surgery was performed with no change in the level of anticoagulant therapy, and treatment with the anticoagulant agent was continued after surgery. Before it was sutured, the operative field was irrigated in 19 patients with 10 ml of a 4.8 percent aqueous solution of tranexamic acid (an inhibitor of fibrinolysis) and in 20 patients with a placebo solution. For seven

NEJM1989

3544. Interrelations among children, parents, premedication, and anaesthetists in paediatric day stay surgery.

Interrelations among children, parents, premedication, and anaesthetists in paediatric day stay surgery. 2513966 1990 02 22 1990 02 22 2013 10 02 0959-8138 299 6712 1989 Dec 02 BMJ (Clinical research ed.) BMJ Interrelations among children, parents, premedication, and anaesthetists in paediatric day stay surgery. 1371-5 To investigate the incidence of difficulties associated with parental presence during the induction of anaesthesia in children and the influence of premedication with special (...) reference to vomiting after papaveretum. Mixed factual and multiple choice questionnaire completed by medical and nursing staff and parents during and after admission. Teaching hospital with regional paediatric general surgical unit where parental presence during induction of anaesthesia is long established. 151 Children aged 1-14 years who had not previously undergone surgery attending with parents for day stay general surgical procedures. Children were randomly allocated to receive no premedication

BMJ1989 Full Text: Link to full Text with Trip Pro

3545. A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery.

A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. 2682243 1989 12 18 1989 12 18 2013 11 21 0028-4793 321 21 1989 Nov 23 The New England journal of medicine N. Engl. J. Med. A trial of desmopressin (1-desamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. 1437-43 Previous studies have suggested that desmopressin may reduce the bleeding diathesis that often complicates open-heart surgery (...) . To pursue this question further, we performed a double-blind, randomized, placebo-controlled trial to determine whether the previously reported beneficial effect of desmopressin on hemostasis during complex cardiac surgery was applicable to all elective cardiac surgical procedures involving cardiopulmonary bypass. In 150 consecutive patients, most of whom underwent primary coronary-artery bypass grafting, we compared the effects of intravenous desmopressin (0.3 microgram per kilogram of body weight

NEJM1989

3546. Economic evaluation of cataract surgery: a comparison between IOL and non-IOL techniques

Economic evaluation of cataract surgery: a comparison between IOL and non-IOL techniques Economic evaluation of cataract surgery: a comparison between IOL and non-IOL techniques Economic evaluation of cataract surgery: a comparison between IOL and non-IOL techniques Tuominen R, Immonen I, Raivio I Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions (...) visit, operation, hospital stay, polyclinic, complications, travel, sick leave, home health care following operation, spectacles and contact lenses, lens cleaning, post-operative consultations, and private fees. Price information related to 1986. Currency Finnish Marks (FIM). Sensitivity analysis No sensitivity analysis was carried out. Estimated benefits used in the economic analysis From the literature, the authors assumed that IOL surgery presents optical advantages. Cost results Inclusion

NHS Economic Evaluation Database.1988

3547. Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer.

Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer. 2895214 1988 04 26 1988 04 26 2015 06 16 0140-6736 1 8587 1988 Mar 26 Lancet (London, England) Lancet Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer. 679-81 116 patients aged 70 or over who were judged to have surgically resectable cancer of the breast were prospectively randomised to tamoxifen 20 mg daily or surgical resection. At a median follow-up (...) . Markopoulos C C Ford H T HT Coombes R C RC Bland J M JM Dixon R C RC eng Clinical Trial Comparative Study Journal Article Randomized Controlled Trial England Lancet 2985213R 0140-6736 094ZI81Y45 Tamoxifen AIM IM Aged Aged, 80 and over Breast Neoplasms drug therapy mortality pathology surgery therapy Clinical Trials as Topic Female Follow-Up Studies Humans Mastectomy Neoplasm Recurrence, Local Prospective Studies Random Allocation Tamoxifen therapeutic use 1988 3 26 1988 3 26 0 1 1988 3 26 0 0 ppublish

Lancet1988

3548. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study.

Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. 3260659 1988 08 24 1988 08 24 2006 11 15 0028-4793 319 6 1988 Aug 11 The New England journal of medicine N. Engl. J. Med. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. 332-7 We studied survival rates among 767 men with good left ventricular function who participated in the European Coronary Surgery Study, 10 to 12 years after they were randomly assigned to either early (...) coronary bypass surgery or medical therapy. At the projected five-year follow-up interval, we observed a significantly higher survival rate (+/- 95 percent confidence interval) in the group that was assigned to surgical treatment than in the group assigned to medical treatment (92.4 +/- 2.7 vs. 83.1 +/- 3.9 percent; P = 0.0001). During the subsequent seven years, the percentage of patients who survived decreased more rapidly in the surgically treated than in the medically treated group (70.6 +/- 5.8 vs

NEJM1988

3549. Urinary-bladder management after total joint-replacement surgery.

Urinary-bladder management after total joint-replacement surgery. 3393193 1988 08 24 1988 08 24 2006 11 15 0028-4793 319 6 1988 Aug 11 The New England journal of medicine N. Engl. J. Med. Urinary-bladder management after total joint-replacement surgery. 321-6 We conducted a randomized study of 100 patients to examine the efficacy and risks of two methods of urinary-bladder management after total joint-replacement surgery. Patients who had hip or knee replacement were randomly assigned either (...) 0.01) and was associated with an increased need for subsequent long-term catheterization. There was no significant difference between the groups in the rates of urinary tract infection (11 vs. 15 percent). We could not identify patients at high risk for retention or infection on the basis of preoperative urinary symptoms, previous urinary tract surgery, previous urinary tract infection or urinary retention, high-risk medical conditions, sex, type of anesthesia, or age (in the absence

NEJM1988

3550. Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients.

Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients. 2897517 1988 07 11 1988 07 11 2015 06 16 0140-6736 1 8597 1988 Jun 04 Lancet (London, England) Lancet Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients. 1245-9 To evaluate the effectiveness of immune serum globulin (ISG) in preventing non-A, non-B hepatitis, 291 heart surgery patients who received blood from voluntary donors

Lancet1988

3551. Influence of postoperative anticoagulant treatment on patient survival after femoropopliteal vein bypass surgery.

Influence of postoperative anticoagulant treatment on patient survival after femoropopliteal vein bypass surgery. 2895319 1988 05 10 1988 05 10 2015 06 16 0140-6736 1 8589 1988 Apr 09 Lancet (London, England) Lancet Influence of postoperative anticoagulant treatment on patient survival after femoropopliteal vein bypass surgery. 797-9 To examine whether anticoagulants given after autologous saphenous bypass surgery influenced patient survival 119 patients who received such a graft (...) than 0.043, Mantel). Graft occlusions occurred in 11 patients in the treatment group and in 17 controls. When these patients were excluded from the analysis, the difference in probability of survival between the two groups remained significant (p less than 0.009, Breslow; p less than 0.013, Mantel). Kretschmer G G 1st Clinic of Surgery, University of Vienna, Austria. Wenzl E E Schemper M M Polterauer P P Ehringer H H Marçosi L L Minar E E eng Clinical Trial Journal Article Randomized Controlled

Lancet1988

3552. A cost-effectiveness analysis of prophylaxis against deep-vein thrombosis in major orthopedic surgery

A cost-effectiveness analysis of prophylaxis against deep-vein thrombosis in major orthopedic surgery A cost-effectiveness analysis of prophylaxis against deep-vein thrombosis in major orthopedic surgery A cost-effectiveness analysis of prophylaxis against deep-vein thrombosis in major orthopedic surgery Oster G, Tuden R L, Colditz G A Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary (...) of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Stockings, heparin sodium, warfarin sodium, dihydrergotamine mesylate and intermittent pneumatic compression. Type of intervention Primary prevention. Economic study type Cost-effectiveness analysis. Study population Patients undergoing orthopaedic surgery. Setting The study was carried out in the USA. Dates to which data relate Price related

NHS Economic Evaluation Database.1987

3553. Prevention of venous thromboembolism after general surgery: cost-effectiveness analysis of alternative approaches to prophylaxis

Prevention of venous thromboembolism after general surgery: cost-effectiveness analysis of alternative approaches to prophylaxis Prevention of venous thromboembolism after general surgery: cost-effectiveness analysis of alternative approaches to prophylaxis Prevention of venous thromboembolism after general surgery: cost-effectiveness analysis of alternative approaches to prophylaxis Oster G, Tuden R L, Colditz G A Record Status This is a critical abstract of an economic evaluation that meets (...) the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Stockings, intermittent pneumatic compression, heparin and dihydroergotamine for the prevention of DVT after surgery. Type of intervention Primary prevention. Economic study type Cost-effectiveness analysis. Study population Patients undergoing abdominothoracic

NHS Economic Evaluation Database.1987

3554. Economic evaluation of six scenarios for the treatment of stones in the kidney and ureter by surgery or extra-corporeal shock wave lithotripsy

Economic evaluation of six scenarios for the treatment of stones in the kidney and ureter by surgery or extra-corporeal shock wave lithotripsy Economic evaluation of six scenarios for the treatment of stones in the kidney and ureter by surgery or extra-corporeal shock wave lithotripsy Economic evaluation of six scenarios for the treatment of stones in the kidney and ureter by surgery or extra-corporeal shock wave lithotripsy Patel M S, Blacklock N J, Rao P N Record Status This is a critical (...) abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Extra-corporeal shock wave lithotripsy or surgery for the treatment of stones in the kidney and ureter. Type of intervention Treatment. Economic study type Cost-utility analysis. Study population Patients affected

NHS Economic Evaluation Database.1987

3555. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery.

Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. 2446091 1988 01 13 1988 01 13 2015 06 16 0140-6736 2 8571 1987 Dec 05 Lancet (London, England) Lancet Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. 1289-91 Of 22 patients undergoing repeat open-heart surgery through a previous median sternotomy wound 11 were randomised to receive the serine proteinase inhibitor aprotinin in high dosage (about 700 mg intravenously from

Lancet1987

3556. Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effects on the stress response.

Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effects on the stress response. 2879174 1987 02 11 1987 02 11 2015 06 16 0140-6736 1 8524 1987 Jan 10 Lancet (London, England) Lancet Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effects on the stress response. 62-6 In a randomised controlled trial, preterm babies undergoing ligation of a patent ductus arteriosus were given nitrous oxide and d-tubocurarine, with (n = 8) or without (n (...) = 8) the addition of fentanyl (10 micrograms/kg intravenously) to the anaesthetic regimen. Major hormonal responses to surgery, as indicated by changes in plasma adrenaline, noradrenaline, glucagon, aldosterone, corticosterone, 11-deoxycorticosterone, and 11-deoxycortisol levels, in the insulin/glucagon, molar ratio, and in blood glucose, lactate, and pyruvate concentrations were significantly greater in the non-fentanyl than in the fentanyl group. The urinary 3-methylhistidine/creatinine ratios

Lancet1987

3557. Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effects on the stress response.

Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effects on the stress response. 20928962 2010 10 07 2010 10 12 2015 06 16 0140-6736 1 8527 1987 Jan 31 Lancet (London, England) Lancet Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effects on the stress response. 243-8 In a randomised controlled trial, preterm babies undergoing ligation of a patent ductus arteriosus were given nitrous oxide and d-tubocurarine, with (n = 8) or without (...) (n = 8) the addition of fentanyl (10 micrograms/kg intravenously) to the anaesthetic regimen. Major hormonal responses to surgery, as indicated by changes in plasma adrenaline, noradrenaline, glucagon, aldosterone, corticosterone, 11-deoxycorticosterone, and 11-deoxycortisol levels, in the insulin/glucagon, molar ratio, and in blood glucose, lactate, and pyruvate concentrations were significantly greater in the non-fentanyl than in the fentanyl group. The urinary 3-methylhistidine/creatinine

Lancet1987

3558. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery.

A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. 3531851 1986 10 30 1986 10 30 2015 11 19 0028-4793 315 15 1986 Oct 09 The New England journal of medicine N. Engl. J. Med. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. 925-9 There is experimental evidence that low-molecular-weight (...) fractions of heparin are as effective as the standard form but cause less bleeding. We therefore performed a double-blind, randomized trial comparing PK10169 low-molecular-weight heparin with placebo for the prevention of venous thrombosis in patients undergoing elective hip surgery. Prophylactic treatment with a fixed dose was begun postoperatively and continued for 14 days. Fifty patients in each treatment group underwent surveillance with [125I]fibrinogen leg scanning and impedance plethysmography

NEJM1986

3559. Prospective controlled trial of transhepatic biliary endoprosthesis versus bypass surgery for incurable carcinoma of head of pancreas.

Prospective controlled trial of transhepatic biliary endoprosthesis versus bypass surgery for incurable carcinoma of head of pancreas. 2417075 1986 02 14 1986 02 14 2015 06 16 0140-6736 1 8472 1986 Jan 11 Lancet (London, England) Lancet Prospective controlled trial of transhepatic biliary endoprosthesis versus bypass surgery for incurable carcinoma of head of pancreas. 69-71 53 patients with obstructive jaundice due to incurable carcinoma of the head of the pancreas were randomly allocated (...) to percutaneous transhepatic placement of a permanent biliary endoprosthesis (PTE) or bypass surgery. After exclusions 25 patients in each group were treated. Technical success was achieved in 21 patients (84%) in the PTE group and 19 (76%) in the surgery group. The incidence of postprocedural complications (PTE 7, surgery 8) and 30-day mortality (PTE 2, surgery 5) were similar. Recurrent jaundice occurred more often in the PTE (8/21) than the surgery group (3/19). Duodenal obstruction developed in 3 patients

Lancet1986

3560. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial.

Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial. 3517650 1986 06 17 1986 06 17 2013 11 21 0028-4793 314 22 1986 May 29 The New England journal of medicine N. Engl. J. Med. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial. 1402-6 Bleeding after cardiopulmonary bypass remains a cause for concern, requiring reexploration of the chest in approximately 3 percent of patients

NEJM1986